• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • FDA Approves Repatha to Prevent Heart Attack, Stroke americanpharmaceuticalreview
    December 06, 2017
    The U.S. Food and Drug Administration (FDA) has approved Repatha (evolocumab) as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary revascularizations in adults with established cardiovascular disease.
  • How poliovirus unleashes an attack on glioblastoma fiercebiotech
    September 21, 2017
    Only a handful of patients had received the experimental therapy at the time, and it wasn’t clear if the virus would pan out as a cancer treatment.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service